These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17878753

  • 1. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    Fujiki A, Sakamoto T, Nishida K, Mizumaki K, Inoue H.
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
    [Abstract] [Full Text] [Related]

  • 2. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M.
    Am J Cardiol; 2007 May 15; 99(10):1421-4. PubMed ID: 17493472
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
    Kawamura M, Ito H, Onuki T, Miyoshi F, Minoura Y, Asano T, Tanno K, Kobayashi Y.
    J Cardiol; 2007 Dec 15; 50(6):343-50. PubMed ID: 18186308
    [Abstract] [Full Text] [Related]

  • 4. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM, Therkelsen SK, Bruunsgaard H, Krabbe KS, Pedersen BK, Svendsen JH.
    Scand J Clin Lab Invest; 2009 Dec 15; 69(3):425-32. PubMed ID: 19204850
    [Abstract] [Full Text] [Related]

  • 5. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H.
    Int J Cardiol; 2006 Apr 14; 108(3):346-53. PubMed ID: 15964643
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J, Rodríguez Lera MJ, Fariñas Alvarez C, Hernando JP, Ceballos B, Gutiérrez B, Pérez J, Cuesta JM.
    Rev Esp Cardiol; 2006 Feb 14; 59(2):125-9. PubMed ID: 16540033
    [Abstract] [Full Text] [Related]

  • 7. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
    Fujiki A, Tsuneda T, Sakabe M, Nakagawa K, Mizumaki K, Hirai T, Inoue H.
    Circ J; 2004 Sep 14; 68(9):834-9. PubMed ID: 15329504
    [Abstract] [Full Text] [Related]

  • 8. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M, Mori N, Nakamura D, Lee Y, Yoshimura T, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.
    J Cardiol; 2013 Aug 14; 62(2):117-20. PubMed ID: 23623817
    [Abstract] [Full Text] [Related]

  • 9. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO, Celebi S, Canbay A, Ergun G, Aydogdu S, Diker E.
    Cardiology; 2011 Aug 14; 118(3):168-74. PubMed ID: 21654170
    [Abstract] [Full Text] [Related]

  • 10. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F, Tundo F, Belletti S, Mantero A, Melzi D'eril GV.
    J Cardiovasc Med (Hagerstown); 2008 Jun 14; 9(6):581-8. PubMed ID: 18475126
    [Abstract] [Full Text] [Related]

  • 11. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Kolyvaki SG, Lyrarakis GM, Chlouverakis GI, Vardas PE.
    Heart; 2008 Feb 14; 94(2):200-4. PubMed ID: 17575330
    [Abstract] [Full Text] [Related]

  • 12. Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine.
    Fujiki A, Sakabe M, Nishida K, Sugao M, Tsuneda T, Iwamoto J, Mizumaki K, Inoue H.
    Circ J; 2004 Dec 14; 68(12):1139-45. PubMed ID: 15564697
    [Abstract] [Full Text] [Related]

  • 13. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A, Jung J, Siaplaouras S, Neuberger HR, Mewis C.
    Pacing Clin Electrophysiol; 2006 Jun 14; 29(6):559-63. PubMed ID: 16784419
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial.
    Yamase M, Nakazato Y, Daida H.
    Heart; 2012 Jul 14; 98(14):1067-71. PubMed ID: 22689712
    [Abstract] [Full Text] [Related]

  • 15. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I, Ahlmroth H, Jonasson L, Englund A, Jönsson A, Säfström K, Walfridsson H.
    Europace; 2008 Jul 14; 10(7):848-53. PubMed ID: 18523031
    [Abstract] [Full Text] [Related]

  • 16. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation.
    Leftheriotis DI, Fountoulaki KT, Flevari PG, Parissis JT, Panou FK, Andreadou IT, Venetsanou KS, Iliodromitis EK, Kremastinos DT.
    Int J Cardiol; 2009 Jul 10; 135(3):361-9. PubMed ID: 18640731
    [Abstract] [Full Text] [Related]

  • 17. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G, Pizzuto C, Sutera L, Guttilla D, Di Gesaro G, Cascio C, Novo G, Assennato P, Novo S.
    Minerva Cardioangiol; 2007 Jun 10; 55(3):311-5. PubMed ID: 17534249
    [Abstract] [Full Text] [Related]

  • 18. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
    Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M, Altinbas A.
    Am J Cardiol; 2006 May 15; 97(10):1490-3. PubMed ID: 16679090
    [Abstract] [Full Text] [Related]

  • 19. Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation.
    Kawamura M, Ito H, Onuki T, Miyoshi F, Watanabe N, Asano T, Tanno K, Kobayashi Y.
    J Cardiovasc Pharmacol; 2010 May 15; 55(5):511-7. PubMed ID: 20164787
    [Abstract] [Full Text] [Related]

  • 20. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
    Rizos I, Rigopoulos AG, Kalogeropoulos AS, Tsiodras S, Dragomanovits S, Sakadakis EA, Faviou E, Kremastinos DT.
    J Hum Hypertens; 2010 Jul 15; 24(7):447-57. PubMed ID: 20072146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.